Situación de salud del profesorado de la Universidad Central de Venezuela asociada a factores de riesgo para sarcopenia: un análisis descriptivo

Health status of the academic staff at the Central University of in relation to risk factors for sarcopenia: a descriptive analysis

Authors

  • Keta Stephany Escuela de Trabajo Social y Doctorado de Salud Pública, Universidad Central de Venezuela

DOI:

https://doi.org/10.37910/RDP.2026.15.3.e472

Keywords:

Sarcopenia, Metabolic syndrome, Aging, Comorbidity, Risk factors, Noncommunicable diseases

Abstract

The objective of the present study was to describe the health status of professors at the Central University of Venezuela (UCV), to identify, based on the literature, risk factors associated with sarcopenia, to compare these factors with the observed clinical profile, and to estimate the prevalence of sarcopenia within the cohort. A descriptive study was conducted based on data from the 2023 Comprehensive Medical Examination of the IPP-UCV, alongside a narrative review of specialized literature. Diagnoses were standardized and classified into risk categories; subsequently, the theoretical volume of probable clinical events was estimated based on internationally reported prevalence ranges. The sample exhibited a female predominance (60.28%) and an aging age structure, with over 70% of the participants falling between 51 and 80 years of age. A total of 524 distinct diagnoses were recorded, with essential hypertension, hypercholesterolemia, hyperglycemia, and obesity being the most prevalent. The literature review identified 17 risk factors for sarcopenia, distributed across nine clinical categories. A comparison between the literature and the observed health status revealed a higher concentration of diagnoses within the metabolic and cardiorespiratory groups. The overall estimation projected between 189 and 347 probable clinical events of sarcopenia within the studied population, with heart failure, type 2 diabetes mellitus, and chronic kidney disease contributing most significantly to this total. Furthermore, 76.5% of the patients presented with multimorbidity, confirming that this is a population characterized by high clinical complexity. The evaluated cohort exhibits a high cardiometabolic burden and a risk profile consistent with a vulnerability to sarcopenia.

References

1. Cao L, Morley J. Sarcopenia Is Recognized as an Independent Condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) Code. Journal of the American Medical Directors Association. 2016; 17(8): 675-677.

2. Cruz-Jentoft A, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T. Sarcopenia: revised European consensus on definition and diagnosis. Age and Ageing. 2019; 48(1): 16-31.

3. Chen L, Woo J, Assantachai P, Auyeung T, Chou M, Iijima K. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. Journal of the American Medical Directors Association. 2020; 21(3): 300-307.

4. 4Beaudart C, Zaaria M, Pasleau F, Reginster J, Bruyère O. Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis. PLoS One. 2017; 12(1): e0169548.

5. Papadopoulou S, Tsintavis P, Potsaki G, Papandreou D. Sarcopenia: A Contemporary Health Problem among Older Adult Populations. Nutrients. 2020; 12(5): 1293.

6. Han M, Ko H, Choi S, Park S. Association of Protein Intake with Sarcopenia and Related Indicators Among Korean Older Adults: A Systematic Review and Meta-Analysis. Nutrients. 2024; 16(24): 4350.

7. Coelho-Junior H, Calvani R, Marzetti E, Picca A, Landi F, Uchida M. Protein Intake and Sarcopenia in Older Adults: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 2022; 19(14): 8718.

8. Widajanti N, Vitayani S, Damayanti R, Dharmanta R, Usman M, Turchan A. The Effect of Vitamin D Supplementation to Parameter of Sarcopenia in Elderly People: a Systematic Review and Meta-Analysis. Canadian Geriatrics Journal. 2024; 27(1): 63-75.

9. Remelli F, Vitali A, Zurlo A, Volpato S. Vitamin D Deficiency and Sarcopenia in Older Persons. Nutrients. 2019; 11(12): 2861.

10. Sha T, Li J, Mo S, Huang W. Smoking, alcohol and risk of sarcopenia: a Mendelian randomisation study. BMJ Open. 2024; 14(11): e091656.

11. Steffl M, Bohannon R, Petr M, Kohlikova E, Holmerova I. Alcohol consumption as a risk factor for sarcopenia - a meta-analysis. BMC Geriatrics. 2016; 16: 99.

12. Ai Y, Zhao G, Zhao J, Tang Z, Li G. The prevalence and risk factors of sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetology and Metabolic Syndrome. 2021; 13: 93.

13. Anagnostis P, Gkekas N, Athyros V, Paschou S, Ratcliffe T, Nigdelis M. Type 2 Diabetes Mellitus is Associated with Increased Risk of Sarcopenia: A Systematic Review and Meta-analysis. Calcified Tissue International. 2020; 107(5): 453-463.

14. Donini L, Busetto L, Bischoff S, Cederholm T, Ballesteros-Pomar M, Batsis J. Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement. Obesity Facts. 2022; 15(3): 321-335.

15. Poggiogalle E, Lubrano C, Gnessi L, Mariani S, Lenzi A, Donini L. Sarcopenic Obesity and Metabolic Syndrome in Adult Caucasian Subjects. Journal of Nutrition, Health and Aging. 2016; 20(9): 958-963.

16. Zhang Y, Zhang J, Ni W, Yuan X, Zhang H, Li P. Sarcopenia in heart failure: a systematic review and meta-analysis. ESC Heart Failure. 2021; 8(2): 1007-1017.

17. Prokopidis K, Witard O, Isanejad M, Meyer K, Nikiphorou E, Giannos P. Are sarcopenia and its individual components linked to all-cause mortality in heart failure? A systematic review and meta-analysis. Clinical Research in Cardiology. 2025; 114(5): 532-540.

18. Benz E, Trajanoska K, Lahousse L, Schoufour J, Terzikhan N, De Roos E. Sarcopenia in COPD: a systematic review and meta-analysis. European Respiratory Review. 2019; 28(154): 190049.

19. Sepúlveda-Loyola W, Rodrigues-Arias F, Arbillaga-Etxarri A, Rodríguez-Chala J, Vilaró J. Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta-analysis. Journal of Cachexia, Sarcopenia and Muscle. 2020; 11(5): 1164-1176.

20. Yu X, Sun S, Zhang S, Hao Q, Zhu B, Teng Y, et al. A pooled analysis of the association between sarcopenia and osteoporosis. Medicine. 2022; CI(46).

21. Dietzel R, Wiemann S, Jörgens S, Zeidler J, Rau R. Prevalence of sarcopenia in patients with rheumatoid arthritis using the revised EWGSOP2 and the FNIH definition. RMD Open. 2022; 8(2): e002600.

22. Ngeuleu A, Allali F, Hamidou B, Abourazzak F, Kichna H, Hmamouchi I. Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors. Rheumatology International. 2017; 37(6): 1015-1020.

23. Chang K, Hsu T, Wu W, Huang K, Han D. Association Between Sarcopenia and Cognitive Impairment: A Systematic Review and Meta-Analysis. Journal of the American Medical Directors Association. 2016; 17(12): 1164.e7-1164.e15.

24. Hart A, Quinn L, Khalil H, Chahine L. The prevalence of sarcopenia in Parkinson's disease and related disorders - a systematic review. Neurological Sciences. 2023; 44(12): 4205-4217.

25. Yan H, Fu Y, Wang W, Lu Z, Hu X, Wang J. Risk factors of stroke-related sarcopenia: a systematic review and meta-analysis. Frontiers in Aging. 2025; 6: 1452708.

26. Cui Y, Yang X, Lu J. Correlation between sarcopenia and cirrhosis: a meta-analysis. Frontiers in Nutrition. 2024; 10: 1342100.

27. antai X, Liu Y, Yeo Y, Praktiknjo M, Mauro E, Hamaguchi Y. Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis. Journal of Hepatology. 2022; 76(3): 588-599.

28. Ribeiro H, Neri S, Oliveira J, Bennett P, Viana J, Vancini R. Association between sarcopenia and clinical outcomes in chronic kidney disease patients: A systematic review and meta-analysis. Clinical Nutrition. 2022; 41(5): 1131-1140.

29. Shachar S, Deal A, Barnett M, Williams G, Kondic A, Nyrop K. Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy. Clinical Cancer Research. 2017; 23(3): 658-665.

30. Deng H, Zha P, Peng L, Wei R, Ni P, Li G. Preoperative sarcopenia is a predictor of poor prognosis of esophageal cancer after esophagectomy: a comprehensive systematic review and meta-analysis. Diseases of the Esophagus. 2019; 32(3): doy115.

31. Klein G. The effect of glucocorticoids on bone and muscle. Osteoporosis and Sarcopenia. 2015; 1(1): 39-45.

32. Smith M, Graff J, Adashek J, Sartor O. Sarcopenia During Androgen-Deprivation Therapy for Prostate Cancer. Journal of Clinical Oncology. 2023; 41(10): 1820-1823.

33. SeyedAlinaghi S, Vahedi F, Tantuoyir M, Ahmadi S, Mehraeen E, Dadras O. A systematic review of sarcopenia prevalence and associated factors in people living with human immunodeficiency virus. Journal of Cachexia, Sarcopenia and Muscle. 2023;14(3):1168-1182.

34. Liu Z, Chen H, Tu Y, Lin P, Wu C, Yang H. Causal relationship between insulin resistance and sarcopenia. Diabetology and Metabolic Syndrome. 2023; 15: 46.

35. Pratt J, De Vito G, Narici M, Segurado R, Dolan J, Conroy J. Genetic Associations with Aging Muscle: A Systematic Review. Cells. 2020; 9(1): 12.

36. Bano G, Trevisan C, Carraro S, Solmi M, Luchini C, Stubbs B. Inflammation and sarcopenia: A systematic review and meta-analysis. Maturitas. 2017; 96: 10-15.

37. Damanti S, Cristaldi G, Ferrandino G, Malorgio M, Sannino L, Gualandris L. Molecular constraints of sarcopenia in the ageing muscle. Frontiers in Aging. 2025; 6: 1588014.

38. Ferri E, Marzetti E, Calvani R, Picca A, Cesari M, Arosio B. Oxidative stress and sarcopenia in the elderly. Journal of Endocrinological Investigation. 2020; 43(1): 1-10.

39. Shigehara K, Izumi K, Kadono Y, Mizokami A. Relationship between Testosterone and Sarcopenia in Older-Adult Men: A Narrative Review. Journal of Clinical Medicine. 2022; 11(20): 6202.

40. Gao Y, Ye S, Liu B, He J, Luo Q, Jiang T. Risk factors for sarcopenia in community setting across the life course: A systematic review. Archives of Gerontology and Geriatrics. 2025; 133: 105807.

Published

2026-11-15

How to Cite

Keta Stephany. (2026). Situación de salud del profesorado de la Universidad Central de Venezuela asociada a factores de riesgo para sarcopenia: un análisis descriptivo: Health status of the academic staff at the Central University of in relation to risk factors for sarcopenia: a descriptive analysis. Revista Digital De Postgrado, 15(3), e472. https://doi.org/10.37910/RDP.2026.15.3.e472

Most read articles by the same author(s)

Obs.: This plugin requires at least one statistics/report plugin to be enabled. If your statistics plugins provide more than one metric then please also select a main metric on the admin's site settings page and/or on the journal manager's settings pages.

Similar Articles

<< < 4 5 6 7 8 9 10 11 12 13 > >> 

You may also start an advanced similarity search for this article.